Where this topic shows up
Our markets on autoimmune diseases, by category.
- Pharmaceuticals · 11
Market reports
Worldwide reports first. Each covers 2024 history, a 2025 base year and forecasts to 2034.
Pharmaceuticals
Axial Spondyloarthritis (axSpA)
Worldwide · 2024–2034
View report PharmaceuticalsCeliac Disease Treatment
Worldwide · 2024–2034
View report PharmaceuticalsIgA Nephropathy Treatment
Worldwide · 2024–2034
View report PharmaceuticalsInflammatory Bowel Disease Treatment
Worldwide · 2024–2034
View report PharmaceuticalsJAK Inhibitors
Worldwide · 2024–2034
View report PharmaceuticalsLupus Treatment
Worldwide · 2024–2034
View report PharmaceuticalsMultiple Sclerosis Drugs
Worldwide · 2024–2034
View report PharmaceuticalsMyasthenia Gravis Treatment
Worldwide · 2024–2034
View report PharmaceuticalsPsoriasis Treatment
Worldwide · 2024–2034
View reportKey companies
Named as key players in the most of these markets.
AbbVie Inc.6 markets here
Eli Lilly and Company6 markets here
Johnson & Johnson5 markets here
Novartis AG5 markets here
Pfizer Inc.5 markets here
Amgen Inc.3 markets here
Roche3 markets here
AstraZeneca2 markets here
Bristol-Myers Squibb2 markets here
Incyte2 markets here
Takeda Pharmaceutical Company Ltd2 markets here
UCB2 markets here
All markets on this topic
Each opens the market's statistics page, with every country we cover.
Pharmaceuticals
Related topics
Need research on autoimmune diseases?
Full reports carry researched sizes, forecasts and company profiles. We also build custom studies.
Acuitas market figures are supplied with each full report. Chart data comes from the public sources named on each chart.